Advocacy Wealth Management Services’s AbbVie ABBV Stock Holding History

Advocacy Wealth Management Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$960K	Buy	3,814 +143	+4%	+$30.8K	0.03%	104
2026 Q1	$798K	Sell	3,671 -56	-2%	-$12.4K	0.04%	110
2025 Q4	$852K	Sell	3,727 -20	-0.5%	-$4.56K	0.04%	107
2025 Q3	$868K	Buy	+3,747	New	+$763K	0.04%	108
2022 Q4	–	Sell	-13	Closed	-$2K	–	42
2022 Q3	$2K	Hold	13	–	–	﹤0.01%	109
2022 Q2	$2K	Hold	13	–	–	﹤0.01%	116
2022 Q1	$2K	Hold	13	–	–	﹤0.01%	140
2021 Q4	$2K	Hold	13	–	–	﹤0.01%	140
2021 Q3	$1K	Hold	13	–	–	﹤0.01%	150
2021 Q2	$1K	Buy	+13	New	+$1.46K	﹤0.01%	166
2017 Q4	–	Sell	-100	Closed	-$9K	–	215
2017 Q3	$9K	Hold	100	–	–	﹤0.01%	201
2017 Q2	$7K	Hold	100	–	–	﹤0.01%	212
2017 Q1	$7K	Hold	100	–	–	﹤0.01%	236
2016 Q4	$6K	Hold	100	–	–	﹤0.01%	236
2016 Q3	$6K	Hold	100	–	–	﹤0.01%	302
2016 Q2	$6K	Sell	100 -586	-85%	-$35.7K	﹤0.01%	329
2016 Q1	$39K	Buy	686 +265	+63%	+$14.8K	0.03%	205
2015 Q4	$25K	Buy	+421	New	+$24.2K	0.03%	244
2013 Q3	$63K	Buy	1,341 +1,170	+684%	+$51.9K	0.17%	99
2013 Q2	$7K	Buy	+171	New	+$7.48K	0.03%	190

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advocacy Wealth Management Services's ABBV Position: Q2 2026 in Review

Advocacy Wealth Management Services increased its AbbVie (ABBV) stake by 3.9% in Q2 2026, buying an estimated $30.8K and bringing the position to 3,814 shares worth $960K. The position accounts for 0.03% of the portfolio, ranked #104.

Advocacy Wealth Management Services first reported a position in ABBV in Q2 2013 and has held it in 20 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Advocacy Wealth Management Services held 3,814 shares of AbbVie worth $960K as of Q2 2026.
Advocacy Wealth Management Services bought 143 AbbVie shares in Q2 2026, an estimated $30.8K.
AbbVie made up 0.03% of Advocacy Wealth Management Services's portfolio in Q2 2026, its #104 holding.
Advocacy Wealth Management Services first reported a position in AbbVie in Q2 2013 and has held it in 20 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advocacy Wealth Management Services's 13F filing for Q2 2026, filed 29 Jul 2026.